U.S. launches new initiative testing tumor drug combinations
LOS ANGELES, June 1 (Xinhua) -- The U.S. National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations, the institute said on Thursday.